Open Access Article
Berkant Kurbanabc,
Begüm Nurpelin Sağlık Özkanbd,
Derya Osmaniyebd,
Serkan Leventde,
Yusuf Özkaybd and
Zafer Asım Kaplancıklı*bf
aDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, 03030 Afyonkarahisar, Turkey
bDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey. E-mail: zakaplan@anadolu.edu.tr
cThe Institute of Graduate Education, Anadolu University, 26470 Eskişehir, Turkey
dCentral Research Laboratory (MERLAB), Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey
eDepartment of Analytical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey
fPharmacy Services, Vocational School of Health Services, Bilecik Şeyh Edebali University, 11000, Bilecik, Turkey
First published on 19th November 2025
Correction for ‘Structure-based design, synthesis, and biological activity evaluation of chalcone–piperazine derivatives as dual AChE and MAO B inhibitors’ by Berkant Kurban et al., RSC Adv., 2025, 15, 40897–40911, https://doi.org/10.1039/D5RA05397H.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2025 |